Retraction: STK35 gene therapy attenuates endothelial dysfunction and improves cardiac function in diabetes
- 1Department of Molecular Pharmacology & Physiology, Morsani College of Medicine, Bryd Alzheimer's Research Institute, University of South Florida, Tampa, FL, United States
- 2Center for Translational Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, PA, United States
- 3Houston Methodist DeBakey Heart & Vascular Center, Houston, TX, United States
- 4Department of Surgery, Morsani College of Medicine, University of South Florida, Tampa, FL, United States
- 5Department of Biomedical Engineering, The University of Alabama at Birmingham, Birmingham, AL, United States
Citation: Joladarashi D, Zhu Y, Willman M, Nash K, Cimini M, Thandavarayan RA, Youker KA, Song X, Ren D, Li J, Kishore R, Krishnamurthy P and Wang L (2022) STK35 Gene Therapy Attenuates Endothelial Dysfunction and Improves Cardiac Function in Diabetes. Front. Cardiovasc. Med. 8:798091. doi: 10.3389/fcvm.2021.798091
Received: 19 October 2021; Accepted: 22 December 2021;
Published: 13 January 2022; Retracted: 09 May 2023.
Edited by:
Nicolle Kraenkel, Charité University Medicine Berlin, GermanyReviewed by:
Zhao Wang, City of Hope National Medical Center, United StatesAmaresh Ranjan, Midwestern University, United States